Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Global cost of chronic disease treatment to top $47 trillion by 2030, more than triple current US national debt by: Ethan A. Huff, staff writer (this was written in 2011)

Excerpt:
"NaturalNews) Between now and 2030, the aggregate global cost of treating the five most common, non-infectious diseases -- cancer, diabetes, heart disease, lung disease, and mental health disorders -- will top $47 trillion, according to a new report released by the World Economic Forum (WEF). And experts warn that if nothing is done to curb this escalating healthcare crisis, the global economy will most certainly collapse due to insurmountable financial insolvency.

To put this astronomical $47 trillion figure into perspective, consider the fact that the current US national debt is just under $15 trillion -- this means that at the current rate of growth, global healthcare costs associated with treating just these five diseases will exceed the US national debt by more than 300 percent in less than 20 years.

Put another way, the entire global gross domestic product (GDP), which represents the final value of all goods and services produced, was $63 trillion in 2010. Based on WEF figures, global treatment costs for the "big five" non-communicable diseases will represent a shocking 75 percent of the current global GDP by 2030."



Article at: http://www.naturalnews.com/033651_chronic_disease_expenditures.html#ixzz32lxwBJqA